The OncoArray Consortium: a network for understanding the genetic architecture of common cancers

CI Amos, J Dennis, Z Wang, J Byun… - … , biomarkers & prevention, 2017 - AACR
Background: Common cancers develop through a multistep process often including
inherited susceptibility. Collaboration among multiple institutions, and funding from multiple …

[HTML][HTML] Lung cancer is also a hereditary disease

PR Benusiglio, V Fallet, M Sanchis-Borja… - European …, 2021 - Eur Respiratory Soc
Pathogenic genetic variants (formerly called mutations) present in the germline of some
individuals are associated with a clinically relevant increased risk of developing lung cancer …

[HTML][HTML] Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised …

J Mateo, N Porta, D Bianchini, U McGovern… - The Lancet …, 2020 - thelancet.com
Background Metastatic castration-resistant prostate cancer is enriched in DNA damage
response (DDR) gene aberrations. The TOPARP-B trial aims to prospectively validate the …

[HTML][HTML] Inherited DNA-repair gene mutations in men with metastatic prostate cancer

CC Pritchard, J Mateo, MF Walsh… - … England Journal of …, 2016 - Mass Medical Soc
Background Inherited mutations in DNA-repair genes such as BRCA2 are associated with
increased risks of lethal prostate cancer. Although the prevalence of germline mutations in …

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

P Polak, J Kim, LZ Braunstein, R Karlic… - Nature …, 2017 - nature.com
Biallelic inactivation of BRCA1 or BRCA2 is associated with a pattern of genome-wide
mutations known as signature 3. By analyzing∼ 1,000 breast cancer samples, we confirmed …

Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma

K Shindo, J Yu, M Suenaga… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Deleterious germline mutations contribute to pancreatic cancer susceptibility and
are well documented in families in which multiple members have had pancreatic cancer …

[HTML][HTML] Genomic subtypes of non-invasive bladder cancer with distinct metabolic profile and female gender bias in KDM6A mutation frequency

CD Hurst, O Alder, FM Platt, A Droop, LF Stead… - Cancer cell, 2017 - cell.com
Bladder cancer incurs a higher lifetime treatment cost than other cancers due to frequent
recurrence of non-invasive disease. Improved prognostic biomarkers and localized therapy …

[HTML][HTML] BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

MS Cline, RG Liao, MT Parsons, B Paten… - PLoS …, 2018 - journals.plos.org
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance
for Genomics and Health (GA4GH) to aggregate BRCA1 and BRCA2 data to support highly …

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

L Fachal, H Aschard, J Beesley, DR Barnes, J Allen… - Nature …, 2020 - nature.com
Genome-wide association studies have identified breast cancer risk variants in over 150
genomic regions, but the mechanisms underlying risk remain largely unknown. These …

[HTML][HTML] BRCA1-and BRCA2-associated hereditary breast and ovarian cancer

N Petrucelli, MB Daly, T Pal - 2022 - europepmc.org
BRCA1-and BRCA2-associated hereditary breast and ovarian cancer (HBOC) is
characterized by an increased risk for female and male breast cancer, ovarian cancer …